Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study (2014)
- Authors:
- USP affiliated authors: GATTAZ, WAGNER FARID - FM ; FORLENZA, ORESTES VICENTE - FM
- Unidade: FM
- DOI: 10.3892/etm.2014.1864
- Subjects: LÍTIO; TRANSTORNO BIPOLAR; DEPRESSÃO
- Language: Inglês
- Imprenta:
- Source:
- Título: Experimental and Therapeutic Medicine
- ISSN: 1792-0981
- Volume/Número/Paginação/Ano: 8, n. 4, p. 1205-1208, 2014
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
-
ABNT
MACHADO-VIEIRA, Rodrigo et al. Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study. Experimental and Therapeutic Medicine, n. 4, p. 1205-1208, 2014Tradução . . Disponível em: https://doi.org/10.3892/etm.2014.1864. Acesso em: 07 out. 2024. -
APA
Machado-Vieira, R., Zanetti, M. V., De Sousa, R. T., Soeiro‑De‑Souza, M. G., Moreno, R. A., Busatto, G. F., & Gattaz, W. F. (2014). Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study. Experimental and Therapeutic Medicine, ( 4), 1205-1208. doi:10.3892/etm.2014.1864 -
NLM
Machado-Vieira R, Zanetti MV, De Sousa RT, Soeiro‑De‑Souza MG, Moreno RA, Busatto GF, Gattaz WF. Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study [Internet]. Experimental and Therapeutic Medicine. 2014 ;( 4): 1205-1208.[citado 2024 out. 07 ] Available from: https://doi.org/10.3892/etm.2014.1864 -
Vancouver
Machado-Vieira R, Zanetti MV, De Sousa RT, Soeiro‑De‑Souza MG, Moreno RA, Busatto GF, Gattaz WF. Lithium efficacy in bipolar depression with flexible dosing: A six-week, open-label, proof-of-concept study [Internet]. Experimental and Therapeutic Medicine. 2014 ;( 4): 1205-1208.[citado 2024 out. 07 ] Available from: https://doi.org/10.3892/etm.2014.1864 - Three plasma metabolites in elderly patients differentiate mild cognitive impairment and Alzheimer's disease: a pilot study
- Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression
- Inhibition of phospholipase A2 in rat brain decreases the levels of total Tau protein
- Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease
- Decreased Levels of Circulating Adiponectin in Mild Cognitive Impairment and Alzheimer’s Disease
- Lithium reduces Gsk3b mRNA levels: implications for Alzheimer Disease
- Mild cognitive impairment (part 2): biological markers for diagnosis and prediction of dementia in Alzheimer's disease
- Long-term, low-dose lithium treatment does not impair renal functional in the elderly: A 2 year randomized, placebo-controlled trial followed by single blind extension
- Low Doses of Lithium Changes PKA, AKT and Tau Protein in Cortical and Hippocampal Neurons Cell Culture
- Long-term sertraline treatment increases expression and decreases phosphorylation of glycogen synthase kinase-3B in platelets of patients with late-life major depression
Informações sobre o DOI: 10.3892/etm.2014.1864 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas